Form D · Other Health Care

REPLIGEN CORP

Waltham, MA · CIK 0000730272

Offering snapshot reported Jun 13, 2019 · SEC filing

Reported sold
$48M
Offering amount: $48M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 31, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 13, 2019Initial$48,000,000No comparison1SEC filing
Aug 8, 2017Initial$238,590,580No comparison8SEC filing
Jun 16, 2014Initial$4,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-341887

Source: Form D, filed Jun 13, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicolas M. Barthelemy Director
Howard Benjamin Executive
Glenn L. Cooper Director
John G. Cox Director
Karen A. Dawes Director
Alfred L. Goldberg Director
Michael A. Griffith Director
Walter C. Herlihy Director, Executive
Anthony Hunt Executive
Tony J. Hunt Director, Executive
Ralf J. Kuriyel Executive
Glenn P. Muir Director
James R. Rusche Executive
Thomas F. Ryan , Jr. Director
Thomas F. Ryan, Jr. Director
Jon K. Snodgres Executive
Daniel P. Witt Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
41 Seyon Street Building 1, Suite 100
Waltham, MA, 02453